Abstract
At the present time, there is no widely agreed definition of postprandial lipaemia (PPL). This lack of a shared definition limits the identification and treatment of patients with exaggerated PPL as well as the evaluation of potential therapeutic agents. PPL is a complex syndrome characterized by non-fasting hypertriglyceridaemia that is associated with an increased risk of vascular events. This review considers the definition of PPL and the methodology for assessing this process.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Current Vascular Pharmacology |
Vol/bind | 9 |
Udgave nummer | 3 |
Sider (fra-til) | 292-301 |
Antal sider | 10 |
ISSN | 1570-1611 |
Status | Udgivet - jun. 2011 |